N/A Completed N=51 Randomized Single-blind Treatment

Chiropractic for Hypertension in Patients

Source: ClinicalTrials.gov NCT01020435 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2018

Primary outcomePrimary: Unadjusted and Adjusted Changes From Baseline in Systolic and Diastolic Blood Pressure at Weeks 1, 3, 6 — -1.2; -5.3; 0.8; -1.7 mmHg

Summary

The investigators propose a prospective randomized 2 arm parallel observer-blinded phase II clinical study comparing a distinct method of upper cervical chiropractic manipulation to a sham technique in 50 individuals with stage I hypertension (systolic blood pressure (SBP): 140-159 mm Hg; diastolic blood pressure (DBP):90-99 mm Hg).

Outcome Measures

Outcome	Result	p-value
PRIMARY Unadjusted and Adjusted Changes From Baseline in Systolic and Diastolic Blood Pressure at Weeks 1, 3, 6	-1.2; -5.3; 0.8; -1.7; -3.6; -3.3	—

Eligibility Criteria

Inclusion Criteria

Age > 21 and 159mm Hg (AND) Avg DBP 99mm Hg
Any single SBP > 160mm Hg or DBP> 100
BMI > 40
Prescription medications with increased risk for CVA
Current use of anti-coagulant medication/blood thinners
Active drug or alcohol addiction or abstinent 2.5mg/dL
Abnormal Liver function tests
Anemia with hematocrit < 30%
Glucose in Urine
Serum potassium <3.4 @ baseline
S/S Renal artery stenosis
Quebec Task Force Classification 4-9
Self-reported Arnold Chiari malformation
Spinal or paraspinal tumors
Dx with disorder that exhibit spinal joint hypermobility (Marfan Syndrome, Ehlers-Danlos Syndrome, Osteogenesis imperfecta)
Unstable endocrine disorders
Osteoporosis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01020435). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.